Animal models of polycystic ovary syndrome: A focused review of rodent models in relationship to clinical phenotypes and cardiometabolic risk

Fertility and Sterility

Volumn 98, Issue 1, 2012, Pages 185-193.e2

  Shi, Danni ^a   Vine, Donna F ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

animal models; cardiovascular disease; endocrine hormones; metabolic syndrome; ovarian morphology; Polycystic ovary syndrome

Indexed keywords

ANDROGEN; ANTIGESTAGEN; ESTROGEN; LETROZOLE; PRASTERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOMETABOLIC RISK; COMPARATIVE STUDY; DISEASE ASSOCIATION; EWE; MORPHOLOGY; MOUSE; NONHUMAN; OVARY POLYCYSTIC DISEASE; PHENOTYPE; PRENATAL EXPOSURE; PRIORITY JOURNAL; RHESUS MONKEY; RODENT;

EID: 84862994368     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2012.04.006     Document Type: Article

References (112)

1. R.J. Norman, D. Dewailly, R.S. Legro, and T.E. Hickey Polycystic ovary syndrome Lancet 370 2007 685 697 (Pubitemid 47285318)
2. R. Homburg Polycystic ovary syndrome Best Pract Res Clin Obstet Gynaecol 22 2008 261 274 (Pubitemid 351297553)
3. S. Franks Polycystic ovary syndrome N Engl J Med 333 1995 853 861
4. A. Dunaif Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis Endocr Rev 18 1997 774 800 (Pubitemid 28009567)
5. H.F. Escobar-Morreale, J.I. Botella-Carretero, G. Villuendas, J. Sancho, and J.L. San Millan Serum interleukin-18 concentrations are increased in the polycystic ovary syndrome: relationship to insulin resistance and to obesity J Clin Endocrinol Metab 89 2004 806 811 (Pubitemid 38269896)
6. D.A. Ehrmann Polycystic ovary syndrome N Engl J Med 352 2005 1223 1236
7. A.J. Cussons, B.G. Stuckey, and G.F. Watts Cardiovascular disease in the polycystic ovary syndrome: new insights and perspectives Atherosclerosis 185 2006 227 239
8. I.F. Stein, and M.L. Leventhal Amenorrhea associated with bilateral polycystic ovaries Am J Obstet Gynecol 29 1935 181 191
9. R. Azziz, E. Carmina, D. Dewailly, E. Diamanti-Kandarakis, H.F. Escobar-Morreale, and W. Futterweit The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report Fertil Steril 91 2009 456 488
10. J.K. Zawadski, and A. Dunaif Diagnostic criteria for polycystic ovary syndrome: towards a rational approach A. Dunaif, J.R. Givens, F.P. Haselstine, G.R. Merriam, Polycystic ovary syndrome 1992 Blackwell Boston 337 384
11. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome Fertil Steril 81 2004 19 25
12. R. Azziz, E. Carmina, D. Dewailly, E. Diamanti-Kandarakis, H.F. Escobar-Morreale, and W. Futterweit Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline J Clin Endocrinol Metab 91 2006 4237 4245 (Pubitemid 44833391)
13. M. Drivdal, E.B. Loken, T.A. Hagve, I. Bergstad, and O. Aagenaes Do patients with lymphoedema cholestasis syndrome 1/Aagenaes syndrome need dietary counselling outside cholestatic episodes? Clin Nutr 29 2010 525 530
14. A.J. Cussons, G.F. Watts, V. Burke, J.E. Shaw, P.Z. Zimmet, and B.G. Stuckey Cardiometabolic risk in polycystic ovary syndrome: a comparison of different approaches to defining the metabolic syndrome Hum Reprod 23 2008 2352 2358
15. B. Trivax, and R. Azziz Diagnosis of polycystic ovary syndrome Clin Obstet Gynecol 50 2007 168 177 (Pubitemid 46279860)
16. D.K. Mahajan Polycystic ovarian disease: animal models Endocrinol Metab Clin North Am 17 1988 705 732 (Pubitemid 19005974)
17. K.B. Singh Persistent estrus rat models of polycystic ovary disease: an update Fertil Steril 84 Suppl 2 2005 1228 1234 (Pubitemid 41396549)
18. C.R. Parker Jr., and V.B. Mahesh Hormonal events surrounding the natural onset of puberty in female rats Biol Reprod 14 1976 347 353
19. D. Apter, T. Butzow, G.A. Laughlin, and S.S. Yen Accelerated 24-hour luteinizing hormone pulsatile activity in adolescent girls with ovarian hyperandrogenism: relevance to the developmental phase of polycystic ovarian syndrome J Clin Endocrinol Metab 79 1994 119 125 (Pubitemid 24221170)
20. V.B. Mahesh, and R.B. Greenblatt Isolation of dehydroepiandrosterone and 17alpha-hydroxy-delta5-pregenolone from the polycystic ovaries of the Stein-Leventhal syndrome J Clin Endocrinol Metab 22 1962 441 448
21. R.V. Haning Jr., J.J. Hua, R.J. Hackett, C.A. Wheeler, G.N. Frishman, and D.B. Seifer Dehydroepiandrosterone sulfate and anovulation increase serum inhibin and affect follicular function during administration of gonadotropins J Clin Endocrinol Metab 78 1994 145 149 (Pubitemid 24026764)
22. S. Roy, V.B. Mahesh, and R.B. Greenblatt Effect of dehydroepiandrosterone and delta4-androstenedione on the reproductive organs of female rats: production of cystic changes in the ovary Nature 196 1962 42 43
23. J.F. Knudsen, A. Costoff, and V.B. Mahesh Dehydroepiandrosterone-induced polycystic ovaries and acyclicity in the rat Fertil Steril 26 1975 807 817
24. J.F. Knudsen, and V.B. Mahesh Initiation of precocious sexual maturation in the immature rat treated with dehydroepiandrosterone Endocrinology 97 1975 458 468
25. Y. Wang, Y. Sun, and H. Qiu Expression of resistin mRNA in adipose tissue of rat model with polycystic ovarian syndrome and its implication J Huazhong Univ Sci Technolog Med Sci 24 2004 621 624 (Pubitemid 41564205)
26. M.T. Lee, E. Anderson, and G.Y. Lee Changes in ovarian morphology and serum hormones in the rat after treatment with dehydroepiandrosterone Anat Rec 231 1991 185 192
27. E. Anderson, G.Y. Lee, and K. O'Brien Polycystic ovarian condition in the dehydroepiandrosterone-treated rat model: hyperandrogenism and the resumption of meiosis are major initial events associated with cystogenesis of antral follicles Anat Rec 249 1997 44 53 (Pubitemid 27391418)
28. H. Henmi, T. Endo, K. Nagasawa, T. Hayashi, M. Chida, and N. Akutagawa Lysyl oxidase and MMP-2 expression in dehydroepiandrosterone-induced polycystic ovary in rats Biol Reprod 64 2001 157 162 (Pubitemid 32044624)
29. R. Beloosesky, R. Gold, B. Almog, R. Sasson, A. Dantes, and A. Land-Bracha Induction of polycystic ovary by testosterone in immature female rats: modulation of apoptosis and attenuation of glucose/insulin ratio Int J Mol Med 14 2004 207 215
30. H. Ota, M. Fukushima, and M. Maki Endocrinological and histological aspects of the process of polycystic ovary formation in the rat treated with testosterone propionate Tohoku J Exp Med 140 1983 121 131 (Pubitemid 13003062)
31. L. Manneras, S. Cajander, A. Holmang, Z. Seleskovic, T. Lystig, and M. Lonn A new rat model exhibiting both ovarian and metabolic characteristics of polycystic ovary syndrome Endocrinology 148 2007 3781 3791 (Pubitemid 47105840)
32. R.S. Legro Diabetes prevalence and risk factors in polycystic ovary syndrome Obstet Gynecol Clin North Am 28 2001 99 109 (Pubitemid 32242543)
33. E.M. Foecking, M. Szabo, N.B. Schwartz, and J.E. Levine Neuroendocrine consequences of prenatal androgen exposure in the female rat: absence of luteinizing hormone surges, suppression of progesterone receptor gene expression, and acceleration of the gonadotropin-releasing hormone pulse generator Biol Reprod 72 2005 1475 1483 (Pubitemid 40696090)
34. M. Demissie, M. Lazic, E.M. Foecking, F. Aird, A. Dunaif, and J.E. Levine Transient prenatal androgen exposure produces metabolic syndrome in adult female rats Am J Physiol Endocrinol Metab 295 2008 E262 E268
35. J.R. Brawer, F. Naftolin, J. Martin, and C. Sonnenschein Effects of a single injection of estradiol valerate on the hypothalamic arcuate nucleus and on reproductive function in the female rat Endocrinology 103 1978 501 512 (Pubitemid 8393728)
36. J.R. Brawer, M. Munoz, and R. Farookhi Development of the polycystic ovarian condition (PCO) in the estradiol valerate-treated rat Biol Reprod 35 1986 647 655 (Pubitemid 17193935)
37. M. Simard, J.R. Brawer, and R. Farookhi An intractable, ovary-independent impairment in hypothalamo-pituitary function in the estradiol-valerate-induced polycystic ovarian condition in the rat Biol Reprod 36 1987 1229 1237 (Pubitemid 17107335)
38. P.D. Carriere, J.R. Brawer, and R. Farookhi Pituitary gonadotropin-releasing hormone receptor content in rats with polycystic ovaries Biol Reprod 38 1988 562 567
39. A. Schulster, R. Farookhi, and J.R. Brawer Polycystic ovarian condition in estradiol valerate-treated rats: spontaneous changes in characteristic endocrine features Biol Reprod 31 1984 587 593 (Pubitemid 15208391)
40. E. Stener-Victorin, K. Ploj, B.M. Larsson, and A. Holmang Rats with steroid-induced polycystic ovaries develop hypertension and increased sympathetic nervous system activity Reprod Biol Endocrinol 3 2005 44
41. J. Adams, S. Franks, D.W. Polson, H.D. Mason, N. Abdulwahid, and M. Tucker Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotropin releasing hormone Lancet 2 1985 1375 1379
42. L. Wildt, and G. Leyendecker Induction of ovulation by the chronic administration of naltrexone in hypothalamic amenorrhea J Clin Endocrinol Metab 64 1987 1334 1335 (Pubitemid 17074802)
43. S.A. Khoury, N.E. Reame, R.P. Kelch, and J.C. Marshall Diurnal patterns of pulsatile luteinizing hormone secretion in hypothalamic amenorrhea: reproducibility and responses to opiate blockade and an alpha 2-adrenergic agonist J Clin Endocrinol Metab 64 1987 755 762 (Pubitemid 17044544)
44. P.D. Carriere, R. Farookhi, and J.R. Brawer The role of aberrant hypothalamic opiatergic function in generating polycystic ovaries in the rat Can J Physiol Pharmacol 67 1989 896 901 (Pubitemid 19276566)
45. J. Adams, D.W. Polson, and S. Franks Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism Br Med J (Clin Res Ed) 293 1986 355 359 (Pubitemid 16034121)
46. G.F. McCarthy, and J.R. Brawer Induction of Stein-Leventhal-like polycystic ovaries (PCO) in the rat: a new model for cystic ovarian disease Anat Rec 228 1990 137 144 (Pubitemid 20310544)
47. D. Philibert RU38486: an original multifaceted antihormone in vivo M.K. Agarwal, Andrenal steroid antagonism 1984 Walter de Gruyter Berlin 77 101
48. G. Buffler, and S. Roser New data concerning the role played by progesterone in the control of follicular growth in the rat Acta Endocrinol (Copenh) 75 1974 569 578
49. L. Caligaris, J.J. Astrada, and S. Taleisnik Biphasic effect of progesterone on the release of gonadotropin in rats Endocrinology 89 1971 331 337
50. T. Mori, A. Suzuki, T. Nishimura, and A. Kambegawa Inhibition of ovulation in immature rats by anti-progesterone antiserum J Endocrinol 73 1977 185 186 (Pubitemid 8089505)
51. J.E. Sanchez-Criado, C. Bellido, F. Galiot, F.J. Lopez, and F. Gaytan A possible dual mechanism of the anovulatory action of antiprogesterone RU486 in the rat Biol Reprod 42 1990 877 886 (Pubitemid 20205853)
52. J.E. Sanchez-Criado, A. Sanchez, A. Ruiz, and F. Gaytan Endocrine and morphological features of cystic ovarian condition in antiprogesterone RU486-treated rats Acta Endocrinol (Copenh) 129 1993 237 245 (Pubitemid 23295686)
53. R.W. Rebar Hirsutism, hyperandrogenism, and polycystic ovarian syndrome L.J. DeGroot, Endocrinology 1989 Saunders Philadelphia 1982 1993
54. A. Ruiz, M. Tebar, A. Perez-Romero, M.A. Rol de Lama, and J.E. Sanchez-Criado Serum levels of GH, IGF-I, LH and ovarian steroids in cyclic and RU486-treated rats J Endocrinol Invest 20 1997 611 615 (Pubitemid 28026559)
55. J.H. Liu, G. Garzo, S. Morris, C. Stuenkel, A. Ulmann, and S.S. Yen Disruption of follicular maturation and delay of ovulation after administration of the antiprogesterone RU486 J Clin Endocrinol Metab 65 1987 1135 1140 (Pubitemid 18026847)
56. R.L. Rosenfield Ovarian and adrenal function in polycystic ovary syndrome Endocrinol Metab Clin North Am 28 1999 265 293 (Pubitemid 29242714)
57. T. Luukkainen, O. Heikinheimo, M. Haukkamaa, and P. Lahteenmaki Inhibition of folliculogenesis and ovulation by the antiprogesterone RU 486 Fertil Steril 49 1988 961 963
58. A. Ruiz, R. Aguilar, A.M. Tebar, F. Gaytan, and J.E. Sanchez-Criado RU486-treated rats show endocrine and morphological responses to therapies analogous to responses of women with polycystic ovary syndrome treated with similar therapies Biol Reprod 55 1996 1284 1291 (Pubitemid 26398872)
59. M.S. Smith, M.E. Freeman, and J.D. Neill The control of progesterone secretion during the estrous cycle and early pseudopregnancy in the rat: prolactin, gonadotropin and steroid levels associated with rescue of the corpus luteum of pseudopregnancy Endocrinology 96 1975 219 226
60. P. van der Schoot, G.H. Bakker, and J.G. Klijn Effects of the progesterone antagonist RU486 on ovarian activity in the rat Endocrinology 121 1987 1375 1382 (Pubitemid 17155884)
61. S.C. Sommers Polycystic ovaries revisited C.M. Fenoglio, M. Wolff, Progress in surgical pathology 1980 Masson Publishing New York 221 232
62. G.E. Erickson, and S.S. Yen The polycystic ovary syndrome E.Y. Adashi, P.C.K. Leung, The ovary 1993 Raven Press New York 561 579
63. P.B. Clement Nonneoplastic lesions of the ovary R.J. Kurman, Blaustein's pathology of the female genital tract 1987 Springer-Verlag New York 471 515
64. K. Lakhani, G.M. Prelevic, A.M. Seifalian, W.U. Atiomo, and P. Hardiman Polycystic ovary syndrome, diabetes and cardiovascular disease: risks and risk factors J Obstet Gynaecol 24 2004 613 621 (Pubitemid 39655416)
65. C.J. Corbin, J.M. Trant, K.W. Walters, and A.J. Conley Changes in testosterone metabolism associated with the evolution of placental and gonadal isozymes of porcine aromatase cytochrome P450 Endocrinology 140 1999 5202 5210
66. E. Diamanti-Kandarakis Polycystic ovarian syndrome: pathophysiology, molecular aspects and clinical implications Expert Rev Mol Med 10 2008 e3
67. K. Ajika, L. Krulich, C.P. Fawcett, and S.M. McCann Effects of estrogen on plasma and pituitary gonadotropins and prolactin, and on hypothalamic releasing and inhibiting factors Neuroendocrinology 9 1972 304 315
68. H. Kafali, M. Iriadam, I. Ozardali, and N. Demir Letrozole-induced polycystic ovaries in the rat: a new model for cystic ovarian disease Arch Med Res 35 2004 103 108 (Pubitemid 38316828)
69. J.C. Russell, S.E. Graham, and M. Richardson Cardiovascular disease in the JCR: LA-cp rat Mol Cell Biochem 188 1998 113 126 (Pubitemid 28493324)
70. D. Shi, M.K. Dyck, R.R. Uwiera, J.C. Russell, S.D. Proctor, and D.F. Vine A unique rodent model of cardiometabolic risk associated with the metabolic syndrome and polycystic ovary syndrome Endocrinology 150 2009 4425 4436
71. A.H. Balen, J.S. Laven, S.L. Tan, and D. Dewailly Ultrasound assessment of the polycystic ovary: international consensus definitions Hum Reprod Update 9 2003 505 514 (Pubitemid 38072143)
72. S. Jonard, and D. Dewailly The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest Hum Reprod Update 10 2004 107 117 (Pubitemid 38519332)
73. A.M. Fulghesu, S. Angioni, E. Frau, C. Belosi, R. Apa, and R. Mioni Ultrasound in polycystic ovary syndrome - the measuring of ovarian stroma and relationship with circulating androgens: results of a multicentric study Hum Reprod 22 2007 2501 2508 (Pubitemid 47289066)
74. S.F. O'Brien, J.C. Russell, P.J. Dolphin, and S.T. Davidge Vascular wall function in insulin-resistant JCR: LA-cp rats: role of male and female sex J Cardiovasc Pharmacol 36 2000 176 181 (Pubitemid 30659837)
75. A. Hassan, and C.M. Gordon Polycystic ovary syndrome update in adolescence Curr Opin Pediatr 19 2007 389 397 (Pubitemid 47075618)
76. D. Shi, J.C. Russell, S.D. Proctor, and D.F. Vine Intestinal chylomicronemia and postprandial dyslipidemia in a rodent model of polycystic ovary syndrome Atherosclerosis Suppl 9 2008 92 93
77. S. Franks, M.I. McCarthy, and K. Hardy Development of polycystic ovary syndrome: involvement of genetic and environmental factors Int J Androl 29 2006 278 285
78. A. Sen, and S.R. Hammes Androgens: they don't just make a man out of you Exp Rev Obstet Gynecol 6 2011 23 26
79. J.W. Everett Central neural control of reproductive functions of the adenohypophysis Physiol Rev 44 1964 373 431
80. C.E. McCormack, and R. Sridaran Timing of ovulation in rats during exposure to continuous light: evidence for a circadian rhythm of luteinizing hormone secretion J Endocrinol 76 1978 135 144 (Pubitemid 8275526)
81. K.B. Singh Induction of polycystic ovarian disease in rats by continuous light. I. The reproductive cycle, organ weights, and histology of the ovaries Am J Obstet Gynecol 103 1969 1078 1083
82. K.B. Singh Persistent estrus: an experimental model of the polycystic ovary syndrome Obstet Gynecol Surv 24 1969 2 17
83. M. Bradshaw, and V. Critchlow Pituitary concentration of luteinizing hormone in three types of "constant estrous" rats Endocrinology 78 1966 1007 1014
84. I.E. Lowton, and N.B. Schwartz Pituitary ovarian function in rats exposed to constant light: a chronological study Endocrinology 81 1967 497
85. Y. Takeo Influence of continuous illumination on estrous cycle of rats: time course of changes in levels of gonadotropins and ovarian steroids until occurrence of persistent estrus Neuroendocrinology 39 1984 97 104 (Pubitemid 14053006)
86. E. Beys, T. Hodge, and G.J. Nohynek Ovarian changes in Sprague-Dawley rats produced by nocturnal exposure to low intensity light Lab Anim 29 1995 335 338
87. M.K. Dyck, A.F. Parlow, J.F. Senechal, M.A. Sirard, and F. Pothier Ovarian expression of human insulin-like growth factor-I in transgenic mice results in cyst formation Mol Reprod Dev 59 2001 178 185 (Pubitemid 32391243)
88. J.T. Kero, E. Savontaus, M. Mikola, U. Pesonen, M. Koulu, and R.A. Keri Obesity in transgenic female mice with constitutively elevated luteinizing hormone secretion Am J Physiol Endocrinol Metab 285 2003 E812 E818
89. J.K. Devin, J.E. Johnson, M. Eren, L.A. Gleaves, W.S. Bradham, and J.R. Bloodworth Jr. Transgenic overexpression of plasminogen activator inhibitor-1 promotes the development of polycystic ovarian changes in female mice J Mol Endocrinol 39 2007 9 16 (Pubitemid 47337862)
90. D.A. Dumesic, D.H. Abbott, J.R. Eisner, and R.W. Goy Prenatal exposure of female rhesus monkeys to testosterone propionate increases serum luteinizing hormone levels in adulthood Fertil Steril 67 1997 155 163 (Pubitemid 26428430)
91. D.A. Dumesic, D.H. Abbott, and V. Padmanabhan Polycystic ovary syndrome and its developmental origins Rev Endocr Metab Disord 8 2007 127 141 (Pubitemid 47434646)
92. D.H. Abbott, D.K. Barnett, C.M. Bruns, and D.A. Dumesic Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome? Hum Reprod Update 11 2005 357 374 (Pubitemid 40895465)
93. R.W. Goy, F.B. Bercovitch, and M.C. McBrair Behavioral masculinization is independent of genital masculinization in prenatally androgenized female rhesus macaques Horm Behav 22 1988 552 571 (Pubitemid 19008881)
94. R.W. Goy, H. Uno, and S.A. Sholl Psychological and anatomical consquences of prenatal exposure to androgens in female rhesus T. Mori, H. Nagasawa, Toxicity of hormones in perinatal life 1988 CRC Press Boca Raton, FL 127 142
95. D.H. Abbott, D.A. Dumesic, J.R. Eisner, R.J. Colman, and J.W. Kemnitz Insights into the development of polycystic ovary syndrome (PCOS) from studies of prenatally androgenized female rhesus monkeys Trends Endocrinol Metab 9 1998 62 67 (Pubitemid 28207615)
96. D.H. Abbott, J.R. Eisner, R.J. Colman, J.W. Kemnitz, and D.A. Dumesic Prenatal androgen excess programs for PCOS in female rhesus monkeys R.J. Chang, A. Dunaif, J. Hiendel, Polycystic ovary syndrome 2002 Marcel Dekker New York 119 133
97. J.R. Eisner, D.A. Dumesic, J.W. Kemnitz, and D.H. Abbott Timing of prenatal androgen excess determines differential impairment in insulin secretion and action in adult female rhesus monkeys J Clin Endocrinol Metab 85 2000 1206 1210 (Pubitemid 32269373)
98. J.A. Resko, A.E. Buhl, and C.H. Phoenix Treatment of pregnant rhesus macaques with testosterone propionate: observations on its fate in the fetus Biol Reprod 37 1987 1185 1191 (Pubitemid 18049203)
99. J.R. Eisner, D.A. Dumesic, J.W. Kemnitz, R.J. Colman, and D.H. Abbott Increased adiposity in female rhesus monkeys exposed to androgen excess during early gestation Obes Res 11 2003 279 286 (Pubitemid 41127397)
100. Abbott DH TA, Dumesic DA. Fetal, infant, adolescent and adult phenotypes of polycystic ovary syndrome in prenatally androgenized female rhesus monkeys. Am J Primatol 2009;71:776-84.
101. V. Padmanabhan, A. Veiga-Lopez, D.H. Abbott, S.E. Recabarren, and C. Herkimer Developmental programming: impact of prenatal testosterone excess and postnatal weight gain on insulin sensitivity index and transfer of traits to offspring of overweight females Endocrinology 151 2010 595 605
102. R.A. Birch, V. Padmanabhan, D.L. Foster, W.P. Unsworth, and J.E. Robinson Prenatal programming of reproductive neuroendocrine function: fetal androgen exposure produces progressive disruption of reproductive cycles in sheep Endocrinology 144 2003 1426 1434 (Pubitemid 36428485)
103. W.P. Unsworth, J.A. Taylor, and J.E. Robinson Prenatal programming of reproductive neuroendocrine function: the effect of prenatal androgens on the development of estrogen positive feedback and ovarian cycles in the ewe Biol Reprod 72 2005 619 627 (Pubitemid 40279840)
104. V. Padmanabhan, M. Manikkam, S. Recabarren, and D. Foster Prenatal testosterone excess programs reproductive and metabolic dysfunction in the female Mol Cell Endocrinol 246 2006 165 174 (Pubitemid 43238412)
105. R.A. Forsdike, K. Hardy, L. Bull, J. Stark, L.J. Webber, and S. Stubbs Disordered follicle development in ovaries of prenatally androgenized ewes J Endocrinol 192 2007 421 428 (Pubitemid 46444443)
106. A.J. King, N.B. Olivier, P.S. Mohankumar, J.S. Lee, V. Padmanabhan, and G.D. Fink Hypertension caused by prenatal testosterone excess in female sheep Am J Physiol Endocrinol Metab 292 2007 E1837 E1841
107. C. West, D.L. Foster, N.P. Evans, J. Robinson, and V. Padmanabhan Intra-follicular activin availability is altered in prenatally-androgenized lambs Mol Cell Endocrinol 185 2001 51 59 (Pubitemid 33103953)
108. L.J. Webber, S. Stubbs, J. Stark, G.H. Trew, R. Margara, and K. Hardy Formation and early development of follicles in the polycystic ovary Lancet 362 2003 1017 1021 (Pubitemid 37186878)
109. I.J. Clarke, R.J. Scaramuzzi, and R.V. Short Ovulation in prenatally androgenized ewes J Endocrinol 73 1977 385 389 (Pubitemid 8105484)
110. H.H. Ortega, N.R. Salvetti, and V. Padmanabhan Developmental programming: prenatal androgen excess disrupts ovarian steroid receptor balance Reproduction 137 2009 865 877
111. S.E. Recabarren, V. Padmanabhan, E. Codner, A. Lobos, C. Duran, and M. Vidal Postnatal developmental consequences of altered insulin sensitivity in female sheep treated prenatally with testosterone Am J Physiol Endocrinol Metab 289 2005 E801 E806
112. L.M. Quandt, and R.J. Hutz Induction by estradiol-17 beta of polycystic ovaries in the guinea pig Biol Reprod 48 1993 1088 1094 (Pubitemid 23107810)